PMDT

Programmatic Management of Drug-resistant TB (PMDT): While the causes of multi-drug resistant TB are similar in all high burden countries
(low adherence, weak DOTS, poor treatment compliance, inadequate drug supplies, direct transmission, etc.).

URC Participates in the 44th World Conference on Lung Health

Undefined

URC will again have a significant presence at this year’s Union World Conference on Lung Health from October 30–November 3 in Paris, France. In many of the 22 countries that account for more than 80% of TB cases worldwide, we are supporting national TB programs through innovative approaches to address systemic barriers to effective prevention and treatment. The conference provides an opportunity to share our TB work with thousands of health care professionals, researchers, and advocates.

Below is a list of our activities. We look forward to seeing you there or interacting with you on Twitter @urcchs using #LungHealth

- See more at: http://www.urc-chs.com/recent/news?newsItemID=374#sthash.9tWg43fj.dpuf

URC will again have a significant presence at this year’s Union World Conference on Lung Health from October 30–November 3 in Paris, France. In many of the 22 countries that account for more than 80% of TB cases worldwide, we are supporting national TB programs through innovative approaches to address systemic barriers to effective prevention and treatment. The conference provides an opportunity to share our TB work with thousands of health care professionals, researchers, and advocates.

Information and resources from URC’s TB projects in South Africa, Swaziland, Georgia, Malawi, Bangladesh, Vietnam, Indonesia and Cambodia will be on display, along with URC’s global TB CARE II project at the URC booth. 

Please see attached newsletter or visit the URC web page at http://www.urc-chs.com/recent/news?newsItemID=374 for more information.

 

TB CARE II Bangladesh: Changing Lives of MDR TB Patients

Undefined
Improving management of Multi-Drug-resistant TB (MDR TB) is a special focus of the TB CARE II project. It is estimated that there are 3,800 MDR TB cases annually in Bangladesh. A large proportion of these cases remain undetected and untreated, potentially increasing the risk of infection in the community.
 
It is not possible to combat the threat of MDR TB without a synchronized effort to expand national capacity both for diagnosis and treatment. To this end, the TB CARE II project started two new interventions in 2012. The introduction of Gene Xpert technology has been helping a large number of suspected patients with correct and faster diagnosis of drug resistant TB. The community based approach for management has significantly reduced treatment delays by shortening hospital stays and allowing the patients extended time at home to complete their treatment.
 
These efforts resulted in a substantial increase in the enrolment of MDR TB patients in treatment in less than two years.
This booklet titled ‘Changing Lives of MDR TB Patients’ has been prepared to highlight the impact of MDR TB on patients and their families and to demonstrate the acievements that have been made in improving systems of care. The stories epitomize the trials and tribulations that transpire in the lives of MDR TB patients. We hope these stories will generate awareness about MDR TB and inspire readers to join our fight against TB.
 

TB CARE II Introduces High Level Workshop to Close the Gap on Drug-Resistant TB Among Children

Undefined

Globally, few children with drug-resistant (DR) tuberculosis (TB) are identified, diagnosed, and given an appropriate treatment. Although advances have been made in critical high burden countries such as Bangladesh to increase access to quality care and treatment for DR TB, this disease is still considered largely to be a problem for adults, and children who are infected remain too often in the shadows, unable to access care.

TB CARE II Malawi: Infographic

Infographic

Malawi is a low income country with a population of about 15 million.  TB remains a major public health problem in the country.  According to the WHO World TB Report 2012, there were an estimated 29,000 new cases of TB (all forms) in the year 2011, and approximately 18,000 of these were HIV positive. The HIV pandemic presents a significant challenge to global TB control. The USAID TB CARE II Malawi project, launched in 2010, is a 5 year coordinated effort led by URC in collaboration with Project HOPE and PIH. The project assists the National TB Program in improving TB control and expanding access to high quality TB and TB/HIV services in the public sector.  The project recently developed infographics designed to highlight project successes spanning the past 21 months. 

 

Country Program: 

Treating tuberculosis in the private sector: Cambodia

While AIDS has taken the lead in terms of disease threat to humankind, tuberculosis (TB) remains a serious threat, especially where it attacks people with HIV/AIDS. This report presents 2003–2004 survey data of private sector TB practices in Cambodia so that decision-makers can move forward in ensuring proper case management of TB and stemming its spread while using precious resources effectively.

Online Introductory Course on MDR TB for Physicians

This eight module course on multidrug-resistant tuberculosis (MDR-TB) is designed as a self-study online introductory course on MDR-TB for physicians. Each chapter is accompanied with a quiz based on the content of that chapter.

The course presents general principles of MDR-TB control, it doesn't reflect country specific regulations due to variation in policy and guidlines across borders.

Resources for strengthing Technical Assistance Centers for PMDT

Fighting drug resistant TB requires expertise and innovation. TB CARE II is tackling this need by working with TB policy makers and implementers to develop a network of experts and resources to strengthen national and regional drug resistant TB programs. Building from the expertise available through Partners In Health Technical Assistance Centers (TAC) in Lesotho, Russia and Peru (through PIH sister organization Socios En Salud), TB CARE II is working to support the development of TACs so we can share experiences to build effective PMDT worldwide.

Pages